跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets - SFDA Drug Approval Details
Approvals
/
SFDA
/
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets
Authorized
NCE
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
d8a4bfb10cef18a4
Company
Unknown
Type
NCE
Approval Details
Approval Id
d8a4bfb10cef18a4
Drug Approval Sfda Name
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets
Trade Name
OTEZLA 10 mg 4 tablets + 20 mg 4 tablets + 30 mg 19 tablets
Generic Name
APREMILAST
Register Number
1507245581
Register Year
2018
Drug Type
NCE
Route Of Administration
Oral use
Package Type
Blister
Package Size
27
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
36 Months
Distribution Site
Pharmacy
Description Code
7000000088-10-20-30-100000073665
Price
963.6
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
d8a4bfb10cef18a4
Type
NCE
Back to SFDA Approvals